Abstract
There have been major advances in the understanding of immunological processes in melanoma and in their application to the diagnosis and treatment of this cancer since the last World Congress of Dermatology. The major advance has been in the availability of monoclonal antibodies to define the antigenic properties of melanoma and their use as diagnostic and therapeutic agents. There has been considerable progress in defining the complex interrelations between humoral and cellular immune mechanisms and melanoma cells, and the role these play in host resistance to tumor growth and tumor escape from immune destruction. A distinguished panel of dermatologists and non-dermatologists who have been intimately involved with these advances, participated in the workshop. A summary of their presentations follows.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bystryn, J.C. et al. (1988). Melanoma Immunology. In: Orfanos, C.E., Stadler, R., Gollnick, H. (eds) Dermatology in Five Continents. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83360-1_73
Download citation
DOI: https://doi.org/10.1007/978-3-642-83360-1_73
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83362-5
Online ISBN: 978-3-642-83360-1
eBook Packages: Springer Book Archive